Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND & AIMS">Limited understanding of pruritus mechanisms in cholestatic liver diseases hinders development of antipruritic treatments. Previous studies implicated lysophosphatidic acid (LPA) as a potential mediator of cholestatic pruritus.</AbstractText>METHODS: <AbstractText Label="METHODS">Pruritogenicity of lysophosphatidylcholine (LPC), LPA's precursor, was examined in naïve mice, cholestatic mice, and nonhuman primates. LPC's pruritogenicity involving keratinocyte TRPV4 was studied using genetic and pharmacologic approaches, cultured keratinocytes, ion channel physiology, and structural computational modeling. Activation of pruriceptor sensory neurons by microRNA-146a (miR-146a), secreted from keratinocytes, was identified by in vitro and ex vivo Ca2+ imaging assays. Sera from patients with primary biliary cholangitis were used for measuring the levels of LPC and miR-146a.</AbstractText>RESULTS: <AbstractText Label="RESULTS">LPC was robustly pruritic in mice. TRPV4 in skin keratinocytes was essential for LPC-induced itch and itch in mice with cholestasis. Three-dimensional structural modeling, site-directed mutagenesis, and channel function analysis suggested a TRPV4 C-terminal motif for LPC binding and channel activation. In keratinocytes, TRPV4 activation by LPC induced extracellular release of miR-146a, which activated TRPV1+ sensory neurons to cause itch. LPC and miR-146a levels were both elevated in sera of patients with primary biliary cholangitis with itch and correlated with itch intensity. Moreover, LPC and miR-146a were also increased in sera of cholestatic mice and elicited itch in nonhuman primates.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">We identified LPC as a novel cholestatic pruritogen that induces itch through epithelia-sensory neuron cross talk, whereby it directly activates skin keratinocyte TRPV4, which rapidly releases miR-146a to activate skin-innervating TRPV1+ pruriceptor sensory neurons. Our findings support the new concept of the skin, as a sensory organ, playing a critical role in cholestatic itch, beyond liver, peripheral sensory neurons, and central neural pathways supporting pruriception.</AbstractText>

Recent advances in pathogenesis and management of pruritus in cholestatic liver disease

Research Progress of Cholestatic Liver Disease-Related Pruritus in Chinese Medicine and Western Medicine

Mechanisms of pruritus in cholestasis: understanding and treating the itch

Cholestasis-Associated Pruritus and Its Pruritogens

Structure-guided Discovery of Bile Acid Derivatives for Treating Liver Diseases Without Causing Itch

MRGPRX4 in Cholestatic Pruritus

Cholestatic Pruritus in Children: Conventional Therapies and Beyond

Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments

Consensus on the Diagnosis and Treatment of Cholestatic Liver Diseases (2015, China)

Progress in diagnosis and therapy of extrahepatic manifestations of cholestatic liver diseases

Pathogenesis and Treatment of Pruritus Associated with Chronic Kidney Disease and Cholestasis

Evaluation and Management of Pruritus in Primary Biliary Cholangitis

Recent developments in the pathogenesis of pruritus in bullous pemphigoid

Pruritus in Chronic Liver Disease

Current Status of Cholestasis: Pathogenesis, Diagnosis and Treatment

Sodium/bile acid co-transporter inhibitors currently in preclinical or early clinical development for the treatment of primary biliary cholangitis

Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine

Extrahepatic manifestations of cholestasis

Association of Liver Disease and Chronic Pruritus: A Case–Control Study

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis